Preblick Ryan bought INDV
February 9, 2026 · Form 4 insider transaction
Preblick Ryan bought 113,510 shares of Indivior Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
113,510
Price
$0.00
Total value
N/A
InsiderPreblick Ryan
Role—
SecurityPerformance Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 9, 2026
Filing dateFebruary 12, 2026
Shares owned after113,510
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 3, 2023, the Reporting Person was granted a conditional award for 113,510 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026. The shares will then be subject to an additional two-year Holding Period before the vested Shares are released to the Reporting Person.